NICE ‘Optimised’ Decisions: What is the Recommended Level of Patient Access?

Mehmet Bulut;Phill O’Neill;Amanda Cole

Contract Research from Office of Health Economics

Abstract: The National Institute of Health and Care Excellence (NICE) makes recommendations for the use of interventions including medicines in the National Health Service in England based on their clinical and cost-effectiveness. Over the last 20 years 82% of technology appraisal recommendations have been ‘positive’. However, around one third of these are ‘optimised’ recommendations. In this report we quantify the patient access associated with NICE ‘optimised’ recommendations. We evaluated optimised recommendations published between 2015 and 2019; 40 contained sufficient information to estimate recommended patient access levels. In about two-thirds (65%) of optimised recommendations evaluated, NICE recommended use for less than half of eligible patients. While the justification for these restrictions may be well-founded, more granular reporting of recommendations would help paint a more accurate picture of recommended levels of patient access associated with NICE decision outcomes.

Keywords: NICE; ‘Optimised’; Decisions:; What; is; the; Recommended; Level; of; Patient; Access? (search for similar items in EconPapers)
JEL-codes: I1 (search for similar items in EconPapers)
Date: 2020-07-01
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.ohe.org/publications/nice-optimised-de ... decisions-july-2020/ (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ohe:conres:002280

Access Statistics for this paper

More papers in Contract Research from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).